Neurofilament “NfL“ biomarker and prognostic factor in ALS

Neurofilament “NfL“ concentration is an expression of the disease process and a prognostic factor for ALS progression. However, interpretation of serum NfL concentration is only meaningful and informative in the context of other prognostic factors of ALS.

Our NfL analysis helps to provide a better prognostic estimate for the individual progression of ALS. This may be useful for further treatment and care planning. In principle, the more precise assessment of the course of the disease can be of importance for the further organization of life as well as for the arrangement of medical, technical and social support.

How it works

Our research team is available to advise on the next steps you should take.

Get the ALS Analytics App

Test, track and understand your NfL using the ALS Analytics app, available on the Apple App Store and Google Play

Research made for you

Medical Support at Your Fingertips

No Appointments or Clinics

Direct Delivery of Collection Kits

Same Certified Labs Used by Hospitals

Physician Reviewed Results in 2-5 Days

100% Encrypted

Current Articles about NfL in ALS

European Journal Neurology.

Study of NfL in distinct phenotypes of ALS.

Download

Muscle and Nerve.

NfL response during tofersen treatment.

Download

European Journal of Neurology.

Study of the NfL value as a prognostic factor

Download

Muscle and Nerve.

Response of NfL value to Tofersen therapy

Download

Neurology.

Validation of NfL as a prognostic biomarker in ALS

Download